Posted by Michael Wonder on 10 Dec 2018
Perjeta given green light in Scotland as early stage breast cancer treatment
10 December 2018 - Hundreds of breast cancer patients are expected to benefit after a sought-after drug was approved for use by the NHS in Scotland in certain circumstances.
The SMC has given the green light to Perjeta as a new treatment option before surgery for patients with early stage breast cancer.
The decision brings patients in Scotland level with people in this category south of the border – a fact welcomed by campaigners who have fought for access to the drug.
